Table 1.
NEMESIS-2 | EDSP | Total | ||||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |
Age at baseline | 44.3 | 12.5 | 15.1 | 1.1 | 42.8 | 16.7 |
Sex | N a | % | N a | % | N a | % |
Male | 9143 | 44.7 | 2856 | 51.2 | 11 999 | 46.1 |
Female | 11 312 | 55.3 | 2724 | 48.8 | 14 036 | 53.9 |
Total | 20 455 | 100 | 5580 | 100 | 26 035 | 100 |
Baseline educational levela | ||||||
High | 7591 | 37.1 | 3076 | 55.1 | 10 667 | 41 |
Medium | 6588 | 32.2 | 1548 | 27.7 | 8136 | 31.3 |
Low | 6276 | 30.7 | 956 | 17.1 | 7232 | 27.8 |
Total | 20 455 | 100 | 5580 | 100 | 26 035 | 100 |
T0–T3 Psychotic experiences | ||||||
No | 19 280 | 94.3 | 3865 | 80.6 | 23 145 | 91.7 |
Yes | 1175 | 5.7 | 930 | 19.4 | 2105 | 8.3 |
Total | 20 455 | 100 | 4795 | 100 | 25 250 | 100 |
T0–T3 Cannabis use | ||||||
No | 19 454 | 97.9 | 3802 | 81.3 | 23 256 | 94.8 |
Yes | 412 | 2.1 | 873 | 18.7 | 1285 | 5.2 |
Total | 19 866 | 100 | 4675 | 100 | 24 541 | 100 |
T0–T3 Other drug use | ||||||
0 | 19 648 | 96.1 | 5188 | 93 | 24 836 | 95.4 |
1 | 807 | 3.9 | 392 | 7.0 | 1,199 | 4.6 |
Total | 20 455 | 100 | 5580 | 100 | 26 035 | 100 |
T0–T3 Life event | ||||||
No | 10 711 | 52.4 | 2426 | 43.5 | 13 137 | 50.5 |
Yes | 9744 | 47.6 | 3154 | 56.5 | 12 898 | 49.5 |
Total | 20 455 | 100 | 5580 | 100 | 26 035 | 100 |
T0–T3 any 12-month diagnosis | ||||||
No | 17 784 | 86.9 | 4368 | 78.3 | 22 152 | 85.1 |
Yes | 2671 | 13.1 | 1212 | 21.7 | 3883 | 14.9 |
Total | 20 455 | 100 | 5580 | 100 | 26 035 | 100 |
Highest academic achievement: high = at least higher secondary; medium = lower secondary; low = no/primary.
EDSP, Early Developmental Stages of Psychopathology Study; NEMESIS-2, Netherlands Mental Health Survey and Incidence Study-2.
aNumber of observations clustered within individuals (participants were interviewed 4 times over time).